Daiwa Securities Group’s Axsome Therapeutics AXSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-145
Closed -$26K 1217
2025
Q4
$26K Sell
145
-20
-12% -$2.79K ﹤0.01% 1149
2025
Q3
$20K Sell
165
-12
-7% -$1.35K ﹤0.01% 1138
2025
Q2
$18K Buy
177
+17
+11% +$1.8K ﹤0.01% 1098
2025
Q1
$19K Hold
160
﹤0.01% 1069
2024
Q4
$14K Sell
160
-15
-9% -$1.38K ﹤0.01% 1100
2024
Q3
$16K Hold
175
﹤0.01% 1107
2024
Q2
$14K Hold
175
﹤0.01% 1147
2024
Q1
$14K Hold
175
﹤0.01% 1150
2023
Q4
$14K Hold
175
﹤0.01% 1147
2023
Q3
$12K Hold
175
﹤0.01% 1116
2023
Q2
$13K Hold
175
﹤0.01% 1125
2023
Q1
$11K Hold
175
﹤0.01% 1104
2022
Q4
$13K Buy
175
+46
+36% +$2.75K ﹤0.01% 1098
2022
Q3
$6K Hold
129
﹤0.01% 1153
2022
Q2
$5K Hold
129
﹤0.01% 1168
2022
Q1
$5K Hold
129
﹤0.01% 1171
2021
Q4
$5K Hold
129
﹤0.01% 1192
2021
Q3
$4K Buy
129
+59
+84% +$2.3K ﹤0.01% 1189
2021
Q2
$5K Hold
70
﹤0.01% 1069
2021
Q1
$4K Hold
70
﹤0.01% 1086
2020
Q4
$6K Sell
70
-139
-67% -$10.4K ﹤0.01% 1045
2020
Q3
$15K Buy
209
+14
+7% +$1.09K ﹤0.01% 1016
2020
Q2
$11K Hold
195
﹤0.01% 1064
2020
Q1
$11K Hold
195
﹤0.01% 1055
2019
Q4
$20K Buy
+195
New +$7.88K ﹤0.01% 1014

Other funds holding AXSM

Daiwa Securities Group's AXSM Position: Q1 2026 in Review

Daiwa Securities Group sold out of Axsome Therapeutics (AXSM) in Q1 2026, closing a stake of 145 shares — an estimated $26K sold.

Daiwa Securities Group first reported a position in AXSM in Q4 2019 and held it in 25 quarters. The position peaked at $26K in Q4 2025. 409 funds tracked by Wall St. Rank hold AXSM as of Q1 2026.

  • Daiwa Securities Group reported no remaining Axsome Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Daiwa Securities Group sold 145 Axsome Therapeutics shares in Q1 2026, an estimated $26K.
  • Daiwa Securities Group first reported a position in Axsome Therapeutics in Q4 2019 and held it in 25 quarters.
  • Daiwa Securities Group's Axsome Therapeutics position peaked at $26K in Q4 2025.
  • 409 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q1 2026.

Based on Daiwa Securities Group's 13F filing for Q1 2026, filed 13 May 2026.